ライフサイエンスコーパス: antibody against

1 Empirically derived clusters of IgG antibodies against 19 selected periodontal microorganism

2 Functionality of immunoglobulin G (IgG) antibodies against 24 merozoite antigens was determined

3 Herbivores developed antibodies against 3 different hemagglutinin (HA) subtyp

4 An inhibitory antibody against 4-1BB recapitulated the patients' defec

5 RNA immunoprecipitation with an antibody against 5-hydroxymethylcytosine (hm5C) recovere

6 inically applicable high affinity monoclonal antibodies against a broad range of targets.

7 We assessed if bovine colostral IgG (bIgG) antibodies against a CF, CS17, or antibodies against Csb

8 Induction of maternal antibodies against a commensal Pantoea species confers p

9 To this end, we generated monoclonal antibodies against a conformational AB epitope predicted

10 cluding the magnitude and breadth of binding antibodies against a cross-clade panel of Env antigens,

11 e immunoglobulin repertoire of memory B-cell antibodies against a linear epitope in the central front

12 vely, several wild-type HA vaccines elicited antibodies against a majority of the viruses in the H2 H

13 Antibodies against a subset of conserved "core epitopes"

14 Antibodies against a tyrosine phosphorylation site in th

15 We compared titers of antibodies against A/H1N1, A/H3N2, and B influenza virus

16 n recognized by a broadly neutralizing human antibody against a broad range of H3N2 with high potency

17 hod, we used it to redesign an antiinfluenza antibody against a large panel of more than 500 seasonal

18 Screening the antibody against a panel of 86 clinical E. coli ST131 O2

19 s well as AAV2, suggesting that pre-existing antibodies against AAV2 would not negate the clinical ap

20 Antibodies against AB amyloid are indispensable research

21 nant fusion protein combining a single-chain antibody against activated glycoprotein IIb/IIIa and the

22 ion, which was in line with the finding that antibodies against adenylate cyclase toxin were only eli

23 y of research explores the potential role of antibodies against AGE-modified proteins in pathogenesis

24 Of the selected non-HLA antibodies (against agrin, adipocyte plasma membrane-ass

25 Of the selected non-HLA antibodies (against agrin, APMAP, ARHGDIB, ARHGEF6, AT1R

26 ese mice revealed that immunization elicited antibodies against AipA and Asp14 peptides but not OmpA

27 to stimulate broadly protective neutralizing antibodies against all strains circulating within a subt

28 as a peptide antigen to detect FMDV-specific antibodies against all types of the virus.

29 e screen-printed carbon electrode (SPCE) and antibodies against ALP (anti-ALP) were immobilized using

30 ent study reported that administration of an antibody against alpha(4)beta(7) induced durable virolog

31 human primates reported that infusions of an antibody against alpha(4)beta(7) integrin, in combinatio

32 Rabbit antibodies against AMA1-RON2L, RH5, RIPR or CyRPA were t

33 lves ERK-MAPK-signalling and is inhibited by antibodies against amphiregulin, an EGFR ligand concentr

34 e structure of the epitopes of 28 monoclonal antibodies against amyloid-beta using immunoselection of

35 avenous evinacumab, a fully human monoclonal antibody against angiopoietin-like 3, are not known.

36 r investigated non-HLA antibodies, including antibodies against angiotensin-II type 1 receptor, did n

37 Evinacumab, a monoclonal antibody against ANGPTL3, has shown potential benefit in

38 n between HLA-DQA1*05 and the development of antibodies against anti-TNF agents.

39 cross-protective, nonneutralizing functional antibodies against antigenically drifted A(H7N9) viruses

40 modium vivax, there is a solid evidence that antibodies against antigens present on the gametocyte su

41 S) inflammatory autoimmune disease caused by antibodies against aquaporin-4 (AQP4) expressed on astro

42 , tubulin beta-4B class IVb, vimentin), only antibodies against ARHGDIB (adjusted median fluorescence

43 fectious diseases and humans with detectable antibodies against B. burgdorferi are significantly more

44 ten MBL deficient compared to humans without antibodies against B. burgdorferi.

45 Functionality of antibodies against B. pertussis was measured using B. pe

46 Functionality of antibodies against Bordetella pertussis was measured usi

47 zyme-linked immunosorbent assay, we detected antibodies against both SaCas9 and SpCas9 in 78% and 58%

48 IgA, and histo-blood group antigen-blocking antibodies against both vaccine GI.1 and GII.4c genotype

49 For specific detection of antibodies against C. pneumoniae, we developed novel ELI

50 Brains were labeled with antibodies against calbindin, parvalbumin, calretinin, n

51 By incorporating antibodies against cancer associated surface proteins in

52 The patient was found to have anti-retinal antibodies against carbonic anhydrase II and enolase pro

53 ently shown to be the target of a protective antibody against CCHFV.

54 ls activated with phorbol ester/ionomycin or antibodies against CD3/CD28.

55 In vivo administration of neutralizing antibodies against CD4 prior to HDM sensitization signif

56 gold nanoparticles (GNP) functionalized with antibody against CD44 (GNP-HCIm).

57 injection were cultured with an antagonizing antibody against CD44.

58 irwise combination of 11 parental monoclonal antibodies against CD73 was generated by Fab-arm exchang

59 Some mice were then given injections of antibodies against CD8, CD4, or NK1.1 to deplete immune

60 L/6J) mice and mice were given injections of antibody against CDH11, gemcitabine, or small molecule i

61 d mice were given injections of neutralizing antibodies against chemokines, antagonists, or control a

62 ve individuals with iciHHV-6A/B(+) have more antibodies against CMV pp150 than do CMV-seropositive co

63 neural progenitor cells, and a neutralizing antibody against CNTF reduced the astrogenic effects of

64 induction to prevent or eliminate inhibitory antibodies against coagulation factors.

65 ARGX-117, a humanized inhibitory monoclonal antibody against complement C2.

66 In particular, eculizumab, a monoclonal antibody against complement C5, has been approved by the

67 To elicit antibodies against conserved regions located on capsid p

68 the 1960s and 1970s possess non-neutralizing antibodies against contemporary 3c2.A H3N2 viruses.

69 gical survey to elucidate the specificity of antibodies against contemporary H3N2 viruses in differen

70 orts towards the development of neutralizing antibodies against COVID-19 are summarized.

71 m was used to rapidly and accurately measure antibodies against COVID-19 in human blood serum and dri

72 IgG (bIgG) antibodies against a CF, CS17, or antibodies against CsbD, the minor tip subunit of CS17,

73 Blocking antibodies against cytotoxic T-lymphocyte-associated pro

74 In contrast, antibodies against desmosomal cadherins, including human

75 The neutralizing activity of these antibodies against diverse HIV strains has mostly been m

76 monitoring of drug trough concentrations and antibodies against drugs might help determine whether pa

77 serum-induced differentiation, an inhibitory antibody against Ecad drastically reduced intercellular

78 Cetuximab, a monoclonal neutralizing antibody against EGFR, blocks HIV-associated exosome-enh

79 mouth disease (FMD) include the detection of antibodies against either the viral nonstructural protei

80 The acquisition of antibodies against EPCR-binding CIDRalpha1 domains of Pf

81 tory employees, 101 persons positive for IgG antibodies against Epstein-Barr virus capsid antigen, 21

82 Here we developed antibodies against ERFE to prevent hepcidin suppression

83 The orange-blue cluster (composed of antibodies against Eubacterium nodatum and Actinomyces n

84 Burosumab, a human monoclonal antibody against FGF23, improves phosphate homoeostasis

85 ching to burosumab, a fully human monoclonal antibody against FGF23, in paediatric X-linked hypophosp

86 be found in patients with allergies with IgE antibodies against food or aeroallergens.

87 evels of immunoglobulin G (IgG), IgM and IgA antibodies against four SARS-CoV-2 antigens.

88 r (G-CSF) and administration of neutralizing antibodies against G-CSF only partially restored the mye

89 and PP was determined by immunostaining with antibodies against gamma-H2AX and 53BP1.

90 peptide arrays were generated to screen for antibodies against genotype-derived mismatched epitopes

91 e GG epitopes recognized by mouse monoclonal antibodies against GG and by human antibodies in the ser

92 ncer, as demonstrated by the combined use of antibodies against Globo-H and SSEA4.

93 High levels of antibodies against glutamic acid decarboxylase (GAD) are

94 e feasibility of isolating recombinant phage-antibodies against gluten from a non-immunized library o

95 ) head-based vaccines that elicit protective antibodies against H1N1 influenza viruses have been deve

96 using chromatin immunoprecipitation with an antibody against H3K27Ac.

97 Most human antibodies against HA and NA are directed against epitop

98 ims to assess the prevalence of salivary IgG antibodies against HAV and subsequent incident infection

99 HBeAg), HBV surface antigen (HBsAg), and the antibody against HBsAg (anti-HBs).

100 d predictors of undetectable vaccine-induced antibodies against HBV surface antigen (<10 mIU/mL) amon

101 mune responses with the presence of specific antibodies against HCMVpp65(422-439) and TAF9(134-144),

102 uenza virus infection is mediated largely by antibodies against hemagglutinin (HA) and neuraminidase

103 os(t)ide analogue (NA) therapy; cohort B: 23 antibodies against hepatitis B e antigen (anti-HBe)-posi

104 , anti-hepatitis B core antibody (anti-HBc), antibodies against hepatitis C virus (anti-HCV).

105 Indeed viral transcripts, proteins, and antibody against HERV-K are detected in cancers, auto-im

106 BCG vaccination did not alter levels of antibodies against heterologous pathogens.

107 vaccine elicitation of broadly neutralizing antibodies against HIV-1 is a long-sought goal.

108 rict the development of broadly neutralizing antibodies against HIV-1, but this has not been explicit

109 expand rare B cells that express VRC01-class antibodies against HIV-1.

110 These results suggest that preexisting antibodies against HIV-2, which mediate intertype ADCC,

111 ing the gene for PG9, a broadly neutralising antibody against HIV.

112 Both schedules elicited antibodies against HPV-31 and HPV-45 up to 5 years after

113 Antibodies against human papillomaviruses (HPVs) are bio

114 evious study that described the detection of antibodies against human platelet alloantigens by using

115 However, similarly broadly protective antibodies against IBV NA have not been identified.

116 d sick animals, including those with evident antibodies against IDV.

117 althy and sick animals, including those with antibodies against IDV.

118 ription 1 (Stat1)(-/-) mice and neutralizing antibodies against IFN-gamma and IFN-alpha/beta receptor

119 Administration of neutralizing antibodies against IL-17A to HFD-fed mice reduced intest

120 Secukinumab, a fully human monoclonal antibody against IL-17A, shows significant efficacy in p

121 nts with EoE, we found RPC4046 (a monoclonal antibody against IL13) to reduce histologic and endoscop

122 RPC4046, a recombinant humanized monoclonal antibody against IL13, prevents its binding to the recep

123 inistration of antibiotics or a neutralizing antibody against IL17 to neutrophil-deficient mice resul

124 The RORC inverse agonist GSK805, but not antibodies against IL17A or IL17F, prevented colitis in

125 Neutralizing antibodies against IL1B or administration of the MMP inh

126 Antibodies against IL27 and an FFAR2 agonist reduce tumo

127 Administration of an antibody against IL27 reduced the numbers of colon tumor

128 Injection of antibodies against IL36R significantly reduced establish

129 Antibodies against IL36R were applied to mice with estab

130 l2(-/-) mice and mice given injections of an antibody against IL36R developed less severe colitis and

131 While the therapeutic benefit of monoclonal antibodies against infectious disease agents may be deba

132 Mice were given injections of antibodies against integrin alpha4beta7 or gavaged with

133 A-built nanocarrier called 3DNA coupled with antibodies against intercellular adhesion molecule-1 (IC

134 mice were given injections of a neutralizing antibody against interleukin (IL) 6.

135 litis, with or without a FFAR2 agonist or an antibody against interleukin 27 (IL27).

136 Benralizumab is a monoclonal antibody against interleukin-5 receptor alpha, which is

137 Monoclonal antibodies against K63-linked polyubiquitin specifically

138 We have raised 94 antibodies against key Arabidopsis root proteins, using

139 for stimulating T-cell responses and B-cell antibodies against LASV and allow the design and develop

140 -immunized mice showed more robust titers of antibodies against LcrV, Y. pestis whole-cell lysate (YP

141 Opicinumab is a human monoclonal antibody against LINGO-1, an inhibitor of oligodendrocyt

142 Antibodies against M2e have made it to clinical trials,

143 microsphere Luminex technology that measures antibodies against measles, mumps, rubella, and varicell

144 , we present a novel method for discovery of antibodies against membrane proteins in their native con

145 mation augments generation of donor-specific antibodies against MHC class II antigens.

146 We measured levels of antibodies against microbes (anti-Saccharomyces cerevisi

147 ped monthly and screened for the presence of antibodies against Morogoro virus.

148 Antibodies against mucosal vascular addressin cell adhes

149 We demonstrated that testing of antibodies against multiple antigens increases sensitivi

150 We assessed whether antibodies against multiple HPV types were determinants

151 s and 116 healthy volunteers were tested for antibodies against multiple neuronal antigens implicated

152 zation of IL-1alpha by a specific monoclonal antibody against murine IL-1alpha was highly effective i

153 Neurological disorders with IgG antibodies against myelin-oligodendrocyte glycoprotein (

154 We show that human monoclonal antibodies against NA induced by vaccination and infecti

155 Diverse protective antibodies against NANP repeats are therefore not limite

156 In a small subpopulation of patients, antibodies against native bovine serum albumin (BSA) wer

157 erythematosus (SLE; 15 with NPSLE) showed no antibodies against natively expressed N-methyl-D-asparta

158 vived much better than mice that do not have antibodies against NeSt1.

159 enza virus vaccine development.We found that antibodies against neuraminidase were associated with si

160 Antibodies against neuronal N-methyl-D-aspartate recepto

161 Antibodies against neuronal receptors and synaptic prote

162 In humans, IgG4 antibodies against Nfasc155 are implicated in the pathog

163 dentifying subgroups of patients who harbour antibodies against nodal proteins such as neurofascin an

164 Antibodies against nonvaccine HPV types 31, 33, 45, 52,

165 Several strategies, such as monoclonal antibodies against Notch ligands and receptors, as well

166 , an effect blocked by a monoclonal blocking antibody against NRP1.

167 B-1 cell-derived natural IgM antibodies against oxidation-specific epitopes on low-de

168 y OxPL and inhibited with the E06 monoclonal antibody against OxPL.

169 ge of inhibitory neurochemical types we used antibodies against parvalbumin, calbindin, calretinin, a

170 With amazing rapidity, monoclonal antibodies against PCSK9 were developed and studied in l

171 udy intervention, analysed serum samples for antibodies against PCV10 serotypes by ELISA.

172 Antibodies against PD-L1 function by blocking PD-L1 on t

173 Pembrolizumab is a monoclonal antibody against PD-1 and used to treat patients with st

174 Atezolizumab (a monoclonal antibody against PD-L1), which restores anticancer immun

175 ice were given intraperitoneal injections of antibodies against PD1, T-cell immunoreceptor with Ig an

176 ks (MOFs) is proposed to efficiently protect antibodies against perturbation environments and quickly

177 Antibodies against pertussis toxin (PT), filamentous hae

178 Antibodies against pertussis toxin (PT), filamentous hem

179 We demonstrate that antibodies against PfGARP kill trophozoite-infected eryt

180 mitations (e.g. in MS of phosphopeptides, or antibodies against phosphoepitopes) led to conflicting r

181 Antibodies against phospholipase A(2) receptor 1 (PLA(2)

182 The specific targets of functional antibodies against Plasmodium falciparum merozoites rema

183 Single-drug therapies with monoclonal antibodies against programmed death-1 (PD-1) and program

184 We evaluated the effects of a neutralizing antibody against programmed cell death 1 (PD-1) and an a

185 arcinoma patients treated with nivolumab, an antibody against programmed cell death protein 1 (PD1).

186 veral animal models and induces neutralizing antibodies against protective antigen (PA), the cell-bin

187 large amounts of starting material, specific antibodies against proteins of interest, and/or genetic

188 asma samples from 681 women were assayed for antibodies against recombinant antigens and for IgG and

189 murina-infected mouse lung sections using an antibody against recombinant Bgl2 showed that the native

190 egree to which these assays cross-react with antibodies against related coronaviruses.

191 ded by the discovery of potent and selective antibodies against relevant viral epitopes.

192 PECR, PLA2R, PRKCZ, TUBB4b, vimentin), only antibodies against Rho GDP-dissociation inhibitor 2 (ARH

193 the participants recruited in this study had antibodies against rNiV-N, suggesting possible exposure

194 Cells reacting with antibody against Rothia or Haemophilus were prominent in

195 Low levels of specific antibodies against S pneumoniae were found in 10 of 11 e

196 Here we quantify the pre-existing antibodies against SAgs in many human plasma and IVIG sa

197 Our results indicate that antiviral antibodies against SARS-CoV-2 did not decline within 4 m

198 At >14 days after symptom onset, antibodies against SARS-CoV-2 nucleocapsid protein showe

199 Serum IgG and IgA antibodies against SARS-CoV-2 spike protein were detecte

200 Presence of antibodies against SARS-CoV-2 was assessed using a later

201 r than 10% of the US adult population formed antibodies against SARS-CoV-2, and fewer than 10% of tho

202 y available serologic tests for detection of antibodies against SARS-CoV-2, it remains imperative tha

203 availability of serologic assays to test for antibodies against SARS-CoV-2, most have undergone minim

204 mutation is needed for potently neutralizing antibodies against SARS-CoV-2.

205 Previous studies have shown that rabbit IgG antibodies against Schistosoma mansoni egg antigens (SmS

206 alization studies show that a combination of antibodies against SEA, SEB,and TSST-1 can provide broad

207 T)/chemiresistor architecture with selective antibodies against Sec-delivered effector 1 (SDE1), a se

208 Dysregulated immune responses may lead to antibodies against self-antigens (autoantibodies), resul

209 Antibodies against several bacterial and viral pathogens

210 This study characterizes the prevalence of antibodies against severe acute respiratory syndrome cor

211 erological assays indicating the presence of antibodies against severe acute respiratory syndrome cor

212 ted two fully human, neutralizing monoclonal antibodies against severe acute respiratory syndrome cor

213 had high concentrations of afucosylated IgG antibodies against severe acute respiratory syndrome cor

214 lated with serum-derived cytokine levels and antibodies against severe acute respiratory syndrome-cor

215 f serum immunoglobulin (Ig) levels, specific antibodies against Streptococcus pneumoniae, and allerge

216 by identification of immunoglobulin G (IgG) antibodies against T. gondii embryogenesis-related prote

217 ed a library of 28 epitope-mapped monoclonal antibodies against TcfA and incorporated three antibodie

218 a high affinity, species cross-reactive VNAR antibody against TfR1-ECD that does not compete with tra

219 es neutralizing anti-hemagglutinin (anti-HA) antibodies against that specific infecting influenza str

220 free (SPF) cats for pre-existing AAV-binding antibodies against the 11 serotypes.

221 avis (MG) is an autoimmune disease caused by antibodies against the acetylcholine receptor (AChR), mu

222 ting and neuraminidase-inhibiting functional antibodies against the antigenically drifted A(H7N9) vir

223 otential for the development of neutralizing antibodies against the C-terminal motif of TIMP-1 for di

224 Immunoglobulin G (IgG) antibodies against the capsular polysaccharide (CPS) off

225 expression of IL1B and TNF and production of antibodies against the drug complex.

226 The development of neutralizing antibodies against the flavivirus envelope (E) protein i

227 n serum) on magnetic particles modified with antibodies against the general tetraspanins CD9, CD63 an

228 in inducing binding and tier 1 neutralizing antibodies against the gp120.

229 ssay, PeSHHA, specially for the detection of antibodies against the gp41 protein of HIV-1.

230 childhood exposures affect the induction of antibodies against the hemagglutinin (HA) stalk domain o

231 Antibodies against the hemagglutinin stalk confer protec

232 he vaccines to elicit broadly cross-reactive antibodies against the hemagglutinin stalk domain.

233 otection was associated with vaccine-induced antibodies against the HIV envelope and CD4(+) T cell re

234 r titers of hemagglutination-inhibiting (HI) antibodies against the homologous vaccine antigen, most

235 uding herpes simplex virus 2, and blocked by antibodies against the inflammatory cytokine TNF-alpha.

236 nic Escherichia coli by maternal natural IgG antibodies against the maternal microbiota when antibodi

237 aria-induced anemia is related to autoimmune antibodies against the membrane lipid phosphatidylserine

238 Antibodies against the Membrane-Proximal External Region

239 t for amyloidogenicity and raised polyclonal antibodies against the most amyloidogenic peptide.

240 re we investigated whether function-blocking antibodies against the nerve-fiber growth inhibitory pro

241 In this work, we show that function-blocking antibodies against the nerve-fiber growth inhibitory pro

242 Administration of antibodies against the neutrophil marker Ly6G reduced th

243 bited elevated virus-neutralizing titers and antibodies against the nucleocapsid (N) and the receptor

244 eparations that need to contain neutralizing antibodies against the pathogens in their environment.

245 he overexpression of chaperone DNAJB6 and by antibodies against the polyproline domain of mHTT.

246 Furthermore, antibodies against the recombinant putative lipoprotein

247 pathology, we generated single-chain (scFv) antibodies against the RNA recognition motif 1 (RRM1) of

248 countermeasures is the level of neutralizing antibodies against the SARS-CoV-2 spike protein, which e

249 d mice and convalescent patients to generate antibodies against the severe acute respiratory syndrome

250 after a delay of around 4 months, protecting antibodies against the short L1 appeared, enabling the v

251 o treatment with non-neutralizing monoclonal antibodies against the SIV envelope glycoprotein that on

252 Immunogens inducing antibodies against the stem of influenza virus hemagglut

253 The detection of antibodies against the structural proteins (SP) of the c

254 od and activated in culture using tetrameric antibodies against the surface ligands CD2, CD3 and CD28

255 Commercial antibodies against the target are purchased and tested b

256 HHV-6A/B(+) subjects have significantly more antibodies against the U90 gene product (IE1) than do no

257 vaccines induce strain-specific neutralizing antibodies against the variable immunodominant globular

258 h plasma from recovered patients, monoclonal antibodies against the viral S-protein, and soluble form

259 imal studies suggest that while neutralizing antibodies against the viral spike protein may correlate

260 Belimumab, an antibody against the B cell trophic factor BAFF, was ine

261 We, therefore, generated the Ca37 monoclonal antibody against the C. albicans alcohol dehydrogenase (

262 n gold nanoparticles (GNPs) conjugated to an antibody against the ENaC present on platelets.

263 r replacement of cisplatin with cetuximab-an antibody against the epidermal growth factor receptor-ca

264 n the astrocytes are first incubated with an antibody against the gamma1 subunit of laminin, suggesti

265 ss of MIC2 O-fucosylation, as detected by an antibody against the GlcFuc disaccharide, and in markedl

266 Methods: A humanized monoclonal IgG antibody against the herpes simplex viral protein glycop

267 seed-expressed nanobody-heavy chain (VHH-Fc) antibody against the highly abundant Arabidopsis thalian

268 t the gate electrode functionalized with the antibody against the HIV-1 p24 capsid protein, while it

269 umab, a VelocImmune-derived human monoclonal antibody against the interleukin (IL) 4 receptor, inhibi

270 ich are targeted to organs with a monoclonal antibody against the mouse transferrin receptor.

271 d with spartalizumab, a humanized monoclonal antibody against the programmed death-1 (PD-1) receptor.

272 sma from both parents and one child have IgG antibody against the S1 protein and virus-neutralizing a

273 However, the discovery of antibodies against their targets in their native forms i

274 Children with high breadth of functional antibodies against these antigens together with cMSP33D7

275 The correlation of classes/subclasses of antibodies against these antigens with clinical characte

276 rally different antigens and produce cognate antibodies against these molecules.

277 ary experiments, treatment with neutralizing antibodies against these proinflammatory cytokines or th

278 Antibodies against this site, unable to bind full-length

279 Specific antibodies against three widely used explosives, 2,4,6-t

280 Antibodies against TLR2 or TLR4 did not block the increa

281 Mice given an antibody against TLR2 had prolonged whole gut transit ti

282 Some mice were given a blocking antibody against TLR2 or a TLR4 inhibitor.

283 Moreover, administration of blocking antibodies against TM and EPCR significantly reduced CCM

284 Furthermore, treating with neutralizing antibodies against TNF-alpha and IFN-gamma protected mic

285 Polyclonal antibodies against TNF-alpha suppressed TLR2/4-mediated

286 Blocking antibodies against Toll-like receptor (TLR)1/TLR2, as we

287 uce the efficacy of infliximab, a monoclonal antibody against tumor necrosis factor (TNF), in the tre

288 dfish Erpetoichthys calabaricus, by means of antibodies against tyrosine hydroxylase (TH; the first e

289 Serum samples were analyzed for antibodies against vaccine components, and bivariate and

290 oportion of preterm infants who achieved IgG antibody against vaccine antigens at concentrations abov

291 Antibodies against viral pathogens represent promising t

292 te vaccines that induce broadly neutralizing antibodies against viral pathogens, revealing the specia

293 This tool allows the detection of antibodies against viruses, using a synthetic human viro

294 Antibodies against VP40 and GP are found to predominate

295 Staphylococcus aureus infection elicits antibodies against wall teichoic acid (WTA).

296 roneutralisation assay to measure protective antibodies against yellow fever in Malian and Ghanaian c

297 ercially available monoclonal and polyclonal antibodies against ZIKV and DENV envelope proteins utili

298 Although some studies suggest that antibodies against ZIKV NS1 are protective, their activi

299 , 24.5% of the participants had neutralizing antibodies against ZIKV, suggesting that ZIKV was widely

300 t 35.1% of the participants had neutralizing antibodies against ZIKV.